Bayer (BAYN) Given a €110.00 Price Target at UBS Group

Share on StockTwits

Bayer (FRA:BAYN) has been assigned a €110.00 ($127.91) price objective by analysts at UBS Group in a research note issued to investors on Tuesday, www.boersen-zeitung.de reports. The firm currently has a “buy” rating on the healthcare company’s stock. UBS Group’s price objective suggests a potential upside of 61.96% from the company’s current price.

Several other equities analysts have also recently issued reports on BAYN. Kepler Capital Markets set a €84.00 ($97.67) price objective on Bayer and gave the stock a “buy” rating in a report on Tuesday. JPMorgan Chase & Co. set a €70.00 ($81.40) price objective on Bayer and gave the stock a “neutral” rating in a report on Tuesday. Sanford C. Bernstein set a €86.00 ($100.00) price objective on Bayer and gave the stock a “buy” rating in a report on Friday. Deutsche Bank set a €115.00 ($133.72) price objective on Bayer and gave the stock a “buy” rating in a report on Monday. Finally, Credit Suisse Group set a €77.00 ($89.53) price objective on Bayer and gave the stock a “buy” rating in a report on Tuesday, November 27th. Seven analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the company. The stock has a consensus rating of “Buy” and an average target price of €88.37 ($102.76).

Shares of BAYN stock opened at €67.92 ($78.98) on Tuesday. Bayer has a 1 year low of €91.58 ($106.49) and a 1 year high of €123.82 ($143.98).

Bayer Company Profile

Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, Crop Science, and Animal Health segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents.

Recommended Story: How to find the components of the quick ratio

Analyst Recommendations for Bayer (FRA:BAYN)

Receive News & Ratings for Bayer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Traders Buy Constellation Brands  on Weakness Following Insider Selling
Traders Buy Constellation Brands on Weakness Following Insider Selling
Avangrid  Trading Down 5.2% Following Weak Earnings
Avangrid Trading Down 5.2% Following Weak Earnings
ValuEngine Downgrades Cars.com  to Sell
ValuEngine Downgrades Cars.com to Sell
Inseego  Upgraded at ValuEngine
Inseego Upgraded at ValuEngine
NINTENDO LTD/ADR  Stock Rating Lowered by ValuEngine
NINTENDO LTD/ADR Stock Rating Lowered by ValuEngine
ICU Medical  Set to Announce Quarterly Earnings on Thursday
ICU Medical Set to Announce Quarterly Earnings on Thursday


Leave a Reply

© 2006-2019 Ticker Report